Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home

Cancer

Volumn 85, Issue 8, 1999, Pages 1849-1858

  Mercadante, Sebastiano ^a,b  

^a SAMOT Onlus   (Italy)

^b LA MADDALENA CANCER CENTER   (Italy)

Author keywords

Adjuvant drugs; Adverse effects; Anti inflammatory drugs; Cancer pain; Home palliative care; Opioids; World Health Organization guidelines

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; CARBAMAZEPINE; HALOPERIDOL; LAXATIVE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; STEROID;

ADVANCED CANCER; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CONSTIPATION; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; FOLLOW UP; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; NERVE BLOCK; PAIN ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SPINAL ANESTHESIA; TERMINAL CARE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANALGESIA; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE MANAGEMENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; FEMALE; HOME CARE SERVICES; HOSPICES; HOSPITALIZATION; HUMANS; HYPNOTICS AND SEDATIVES; ITALY; MALE; MIDDLE AGED; NARCOTICS; NEOPLASMS; PAIN; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS; TERMINAL CARE; WORLD HEALTH ORGANIZATION;

EID: 0033561013     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1849::AID-CNCR27>3.0.CO;2-6     Document Type: Article

References (37)

1. World Health Organization. Cancer pain relief. Geneva: World Health Organization, 1986.
2. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987;59:850-6.
3. Takeda F. Results of a field-testing in Japan of the WHO draft interim guideline on relief of cancer pain. Pain Clin 1986;1:83-9.
4. Walker VA, Hoskin PJ, Hanks GW, White ID. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Manage 1988;3: 145-9.
5. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 1995;63:65-76.
6. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-6.
7. Mercadante S. Oral morphine consumption in Italy and Sicily. J Pain Symptom Manage 1998;14:227-30.
8. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. JAMA 1995;274:1870-3.
9. Eisenberg E, Berkey C, Carr DB, Mosteller F, Chalmers C. Efficacy and safety of nonsteroidal antinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 1994;12:2756-65.
10. Ashby MA, Fleming BG, Brooksbank M, Rounsefell B, Runciman WB, Jackson K, et al. Description of a mechanistic approach to pain management in advanced cancer: preliminary report. Pain 1992;51:153-61.
11. Portenoy RK. Cancer pain: pathophysiology and syndromes. Lancet 1992;339:1026-32.
12. Hanks GW, Justins DM. Cancer pain: management. Lancet 1992;339:1031-6.
13. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? grading pain severity by its interference with function. Pain 1995;61: 277-84.
14. De Conno F, Caraceni A, Groff L, Brunelli C, Donati I, Tamburini M, et al. Effect of home care on the place of death of advanced cancer patients. Eur J Cancer 1996;32:1142-7.
15. Schug SA, Zech D, Grond S, Jung H, Meuser T, Stobbe B. A long term survey of morphine in cancer pain patients. J Pain Symptom Manage 1992;7:259-66.
16. Hanks GW, De Conno F, Ripamonti C, Ventafridda V, Hanna M, McQuay HJ, et al. Morphine for cancer pain: modes of administration. Br Med J 1996;312:823-6.
17. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypothesies derived from studies of opioid infusions. Pain 1990;43:273-86.
18. Mercadante S, Sapio M, Caligara M, Serretta R, Dardanoni G. Opioid-sparing effect of diclofenac in cancer pain. J Pain Symptom Manage 1997;14:15-20.
19. Mercadante S, Genovese G, Kargar JA, Maddaloni S, Roccella S, Salvaggio L, et al. Home palliative care: results in 1991 versus 1989. J Pain Symptom Manage 1992;7:414-8.
20. Ventafridda V, De Conno F, Panerai AE, Maresca V, Monza GC, Ripamonti C. Non-steroidal anti-inflammatory drugs as the first step in cancer pain therapy: double-blind, within patient study comparing nine drugs. J Intern Med Res 1990; 18:21-9.
21. Beaver WT. Combination analgesics. Am J Med 1984;77 (Suppl 3A):38-53.
22. Mercadante S, Salvaggio L, Dardanoni G, Agnello A, Garofalo S. Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain. J Pain Symptom Manage 1998; 15:76-81.
23. De Conno F, Ripamonti C, Sbanotto A, Barletta L, Zecca E, Martini C, et al. A clinical study on the use of codeine, oxycodone, dextropropoxyphene, buprenorphine and pentazocine in cancer pain. J Pain Symptom Manage 1991;6: 423-7.
24. Mercadante S. Prevalence, causes and mechanisms of pain in home-care patients with advanced cancer. Pain Clin 1994;7:131-6.
25. Radbruck L, Zech D, Grond S, Jung H, Meuser T. Pain analysis and pain therapy for lung cancer. Chirurg 1994;65: 696-701.
26. Boisvert M, Cohen SR. Opioid use in advanced malignant disease: why do different centers use vastly different doses? a plea for standardized reporting. J Pain Symptom Manage 1995;10:632-8.
27. Bruera E, MacMillan K, Hanson K, MacDonald RN. Palliative care in cancer center: results in 1984 versus 1987. J Pain Symptom Manage 1990;5:1-5.
28. Cherny NJ, Chang V, Frager G, Ingham JM, Tiseo PJ, Popp B, et al. Opioid pharmacotherapy in the management of cancer pain. Cancer 1995;76:1288-93.
29. Mercadante S, Salvaggio L. Cancer pain knowledge in southern Italy: data from a postgraduate refresher course. J Pain Symptom Manage 1996;11:108-15.
30. Zenz M, Willweber-Strumpf A. Opiophobia and cancer pain in Europe. Lancet 1993;341:1075-8.
31. Grond S, Zech D, Schug SA, Lynch J, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 1991;6:411-22.
32. Wenk R, Diaz C, Echeverria M, Aparicio A, Bertucelli N, Courtlon M, et al. Results of cancer pain relief program: a patient care model. J Pain Symptom Manage 1991;6:40-3.
33. Mercadante S, Dardanoini G, Salvaggio L, Armata MG, Agnello A. Monitoring of opioid therapy in advanced cancer patients. J Pain Symptom Manage 1997;13:204-12.
34. Ventafridda V, Caraceni A. Cancer pain. In: PP Raj. Current review of pain. Current Medicine, 1994, 155-78.
35. Mercadante S. Spinal bupivacaine and morphine in advanced cancer patients implanted at home. J Pain Symptom Manage 1994;9:201-7.
36. Hogan Q, Haddox JD, Abram S, Weissman D, Taylor M, Janjan N. Epidural opiates and local anesthetics for the management of cancer pain. Pain 1991;46:271-9.
37. Kerr IG. Clinical trials to study pain in patients with advanced cancer: practical difficulties. Anticancer Drugs 1995;6 (Suppl 3):18-28.